http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107260657-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate | 2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107260657-B |
| titleOfInvention | A kind of slow-release forsythin eye drops and preparation method thereof |
| abstract | The present invention relates to a kind of slow-release forsythin eye drops and preparation method thereof, it is characterized in that using forsythin as pharmacodynamic raw materials, using Polycarbophil and sodium hyaluronate as mucoadhesive polymer medicine-releasing system, be equipped in the acceptable pharmacy of eye part described pharmaceutical adjunct it is prepared at slow release type preparation, the dosage of forsythin and Polycarbophil is by the expression of its weight ratio are as follows: forsythin: Polycarbophil: sodium hyaluronate=1: 0.5~2: 0.5 ~ 5.Related dosage form is eye drops.The slow-release forsythin eye drops local topical prepared by the method for the present invention; with anti-inflammatory, anti-oxidant, antibacterial, anticancer and neuroprotection; it cannot be only used for treating various inflammation of eye section; it can also be used for the post-operative recovery of the ophthalmologic operations such as cataract; it is widely used; the invention has good intraocular penetration, and intraocular bioavilability is higher. |
| priorityDate | 2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.